Article
A Short History of Psychedelic Psychotherapy, Pt. 1
Psychotherapy-assisted psychedelic experiences may revolutionize how we treat mental illness. The philosophy and techniques have evolved over the past 50 years.
Article
Psychotherapy-assisted psychedelic experiences may revolutionize how we treat mental illness. The philosophy and techniques have evolved over the past 50 years.
Article
Part 3 | Dose #3 was the most intense, powerful, horrendous, terrifying, awful experience of my life. In the end, it was all worth it.
Article
Part 2 | This time my dose was 45 mg of pure psilocybin. I took it and waited for the show to begin. There was fear and a sincere hope that this experience would not be as hellish.
Article
A 3-part series on one participant’s high dose psilocybin experience in the Pharmacokinetics of Psilocybin in Normal Adult Volunteers study at the University of Wisconsin.
Article
In underground sessions, you’re taking a huge risk choosing to work with someone who may not have adequately prepared or may have dubious subconscious motivations.
Article
What is neurogenesis? Do psychedelics really cause it? If they do, what doors might that open up?
Article
While much progress has been made, a narrow focus of MDMA just for PTSD obscures the larger applications of MDMA, particularly for those whom traditional psychotherapy has been largely ineffective.
Article
There’s only one way to find out – more scientific experiments.
Article
A research program was seeking volunteers with a spiritual background to ingest a hallucinogen.
Article
Here’s some integrative antidepressant approaches that have low or no side effects and won’t cost you an arm and a leg.
Article
“We cannot imagine events that are connected non-causally and are capable of a non-causal explanation. But that does not mean that such events do not exist.” —Carl Jung
Article
It’s been more than six years since I participated in the Johns Hopkins Spirituality study, but it continues as the most life-changing event of my life.
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture.
We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.